The clinical and cost effectiveness of topotecan for ovarian cancer

C. Forbes, Elizabeth A Shirran, R. A. Lewis, A. M. Bagnall, S. Duffy, J. Kleijnen, G. ter Riet

    Research output: Contribution to journalArticle

    Original languageEnglish
    JournalHealth Technology Assessment
    Volume5
    Issue number28
    Publication statusPublished - 2001

    Cite this

    Forbes, C., Shirran, E. A., Lewis, R. A., Bagnall, A. M., Duffy, S., Kleijnen, J., & ter Riet, G. (2001). The clinical and cost effectiveness of topotecan for ovarian cancer. Health Technology Assessment, 5(28).